RT Journal Article
SR Electronic
T1 The relationship between human mobility measures and SAR-Cov-2 transmission varies by epidemic phase and urbanicity: results from the United States
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.04.15.21255562
DO 10.1101/2021.04.15.21255562
A1 Nishant Kishore
A1 Aimee R. Taylor
A1 Pierre E. Jacob
A1 Navin Vembar
A1 Ted Cohen
A1 Caroline O. Buckee
A1 Nicolas A. Menzies
YR 2021
UL http://medrxiv.org/content/early/2021/04/20/2021.04.15.21255562.abstract
AB Global efforts to prevent the spread of the SARS-COV-2 pandemic in early 2020 focused on non-pharmaceutical interventions like social distancing; policies that aim to reduce transmission by changing mixing patterns between people. As countries have implemented these interventions, aggregated location data from mobile phones have become an important source of real-time information about human mobility and behavioral changes on a population level. Human activity measured using mobile phones reflects the aggregate behavior of a subset of people, and although metrics of mobility are related to contact patterns between people that spread the coronavirus, they do not provide a direct measure. In this study, we use results from a nowcasting approach from 1,396 counties across the US between January 22nd, 2020 and July 9th, 2020 to determine the effective reproductive number (R(t)) along an urban/rural gradient. For each county, we compare the time series of R(t) values with mobility proxies from mobile phone data from Camber Systems, an aggregator of mobility data from various providers in the United States. We show that the reproduction number is most strongly associated with mobility proxies for change in the travel into counties compared to baseline, but that the relationship weakens considerably after the initial 15 weeks of the epidemic, consistent with the emergence of a more complex ecosystem of local policies and behaviors including masking. Importantly, we highlight potential issues in the data generation process, representativeness and equity of access which must be addressed to allow for general use of these data in public health.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding to reportAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Exemption provided by HSPH IRB.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData available through providers.